Macrovascular Complications of Type 2 Diabetes Mellitus.
Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T.
Curr Vasc Pharmacol. 2020;18(2):110-116. doi: 10.2174/1570161117666190405165151.
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, Owens DR, Thomas RL, Song S, Wong J, Chan JC, Luk AO, Penno G, Ji L, Mohan V, Amutha A, Romero-Aroca P, Gasevic D, Magliano DJ, Teede HJ, Chalmers J, Zoungas S.
Diabetologia. 2021 Feb;64(2):275-287. doi: 10.1007/s00125-020-05319-w. Epub 2020 Dec 14.
Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease.
You M, Liu Y, Wang B, Li L, Zhang H, He H, Zhou Q, Cao T, Wang L, Zhao Z, Zhu Z, Gao P, Yan Z.
Cardiovasc Diabetol. 2022 Feb 15;21(1):25. doi: 10.1186/s12933-022-01457-0.
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
Beckman JA, Creager MA, Libby P.
JAMA. 2002 May 15;287(19):2570-81. doi: 10.1001/jama.287.19.2570.
Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes.
Chen T, Xiao S, Chen Z, Yang Y, Yang B, Liu N.
Diabetes Res Clin Pract. 2024 Jan;207:111079. doi: 10.1016/j.diabres.2023.111079. Epub 2023 Dec 26.
Preventing foot ulcers in patients with diabetes.
Singh N, Armstrong DG, Lipsky BA.
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology.
Noor S, Zubair M, Ahmad J.
Diabetes Metab Syndr. 2015 Jul-Sep;9(3):192-9. doi: 10.1016/j.dsx.2015.04.007. Epub 2015 Apr 29.
Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease.
Gazzaruso C, Montalcini T, Gallotti P, Ferrulli A, Massa Saluzzo C, Pujia A, Luzi L, Coppola A.
Endocrine. 2023 Apr;80(1):71-78. doi: 10.1007/s12020-022-03291-6. Epub 2022 Dec 24.
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
Sykora D, Firth C, Girardo M, Tseng A, Wennberg P, Liedl D, Shamoun F.
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Mahé G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Lanéelle D, Mirault T, Darmon P.
Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9.
